Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Wolff

Showing results (631-640 of 831) with videos related to

Pageof 84
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 24, 2014
Risk of marrow neoplasms after adjuvant breast cancer therapy: the national comprehensive cancer network experienceAntonio C Wolff, Amanda L Blackford, Kala Visvanathan, et al.
Bioorganic & Medicinal Chemistry Letters|November 23, 2024
Synthesis and Structure-Activity Relationship of Covalent Inhibitors of SARS-CoV-2 Papain-Like Protease with Antiviral PotencyCatherine C Rouch, Arnab K Chatterjee, Connor McCarty, et al.
Plos One|October 20, 2023
Skills to Enhance Positivity in adolescents at risk for suicide: Protocol for a randomized controlled trialShirley Yen, Nazaret Suazo, Jackson Doerr, et al.
Breast (Edinburgh, Scotland)|January 21, 2023
Clinicopathologic and sociodemographic factors associated with late relapse triple negative breast cancer in a multivariable logistic model: A multi-institution cohort studyAdith Abraham, Carlos H Barcenas, Richard J Bleicher, et al.
NPJ Breast Cancer|February 7, 2020
DNA methylation markers predict recurrence-free interval in triple-negative breast cancerMary Jo Fackler, Soonweng Cho, Leslie Cope, et al.
ESMO Open|December 22, 2024
HER2DX genomic test in early-stage HER2-positive breast cancerS M Tolaney, N Tung, A C Wolff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 4, 2007
Intensive dose-dense compared with high-dose adjuvant chemotherapy for high-risk operable breast cancer: Southwest Oncology Group/Intergroup study 9623Halle C F Moore, Stephanie J Green, Julie R Gralow, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 29, 2025
A Phase II Randomized Study of Paclitaxel alone or combined with Pelareorep with or without Avelumab in Metastatic Hormone Receptor Positive Breast Cancer: the BRACELET-01/PrE0113 studyAmy S Clark, Fengmin Zhao, Paula Klein, et al.
Cell|May 3, 2016
Two Conserved Histone Demethylases Regulate Mitochondrial Stress-Induced LongevityCarsten Merkwirth, Virginija Jovaisaite, Jenni Durieux, et al.
Breast Cancer Research and Treatment|February 26, 2011
Docetaxel metabolism is not altered by imatinib: findings from an early phase study in metastatic breast cancerRoisin M Connolly, Michelle A Rudek, Elizabeth Garrett-Mayer, et al.
Pageof 84

Showing results (631-640 of 831) with videos related to

Sort By:
Pageof 84
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 24, 2014
Risk of marrow neoplasms after adjuvant breast cancer therapy: the national comprehensive cancer network experienceAntonio C Wolff, Amanda L Blackford, Kala Visvanathan, et al.
Bioorganic & Medicinal Chemistry Letters|November 23, 2024
Synthesis and Structure-Activity Relationship of Covalent Inhibitors of SARS-CoV-2 Papain-Like Protease with Antiviral PotencyCatherine C Rouch, Arnab K Chatterjee, Connor McCarty, et al.
Plos One|October 20, 2023
Skills to Enhance Positivity in adolescents at risk for suicide: Protocol for a randomized controlled trialShirley Yen, Nazaret Suazo, Jackson Doerr, et al.
Breast (Edinburgh, Scotland)|January 21, 2023
Clinicopathologic and sociodemographic factors associated with late relapse triple negative breast cancer in a multivariable logistic model: A multi-institution cohort studyAdith Abraham, Carlos H Barcenas, Richard J Bleicher, et al.
NPJ Breast Cancer|February 7, 2020
DNA methylation markers predict recurrence-free interval in triple-negative breast cancerMary Jo Fackler, Soonweng Cho, Leslie Cope, et al.
ESMO Open|December 22, 2024
HER2DX genomic test in early-stage HER2-positive breast cancerS M Tolaney, N Tung, A C Wolff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 4, 2007
Intensive dose-dense compared with high-dose adjuvant chemotherapy for high-risk operable breast cancer: Southwest Oncology Group/Intergroup study 9623Halle C F Moore, Stephanie J Green, Julie R Gralow, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 29, 2025
A Phase II Randomized Study of Paclitaxel alone or combined with Pelareorep with or without Avelumab in Metastatic Hormone Receptor Positive Breast Cancer: the BRACELET-01/PrE0113 studyAmy S Clark, Fengmin Zhao, Paula Klein, et al.
Cell|May 3, 2016
Two Conserved Histone Demethylases Regulate Mitochondrial Stress-Induced LongevityCarsten Merkwirth, Virginija Jovaisaite, Jenni Durieux, et al.
Breast Cancer Research and Treatment|February 26, 2011
Docetaxel metabolism is not altered by imatinib: findings from an early phase study in metastatic breast cancerRoisin M Connolly, Michelle A Rudek, Elizabeth Garrett-Mayer, et al.
Pageof 84